Original article by Jared Lynch
The Australian – Page: 15 : 20-Apr-20
CSL subsidiary Seqirus will produce an additional two million doses of the influenza vaccine, amid strong demand during the coronavirus pandemic. Danielle Dowell of Seqirus says the company is set to supply a record number of flu shots during the 2020 flu season, and stresses that consumers should call their pharmacy or medical clinic ahead of time to ensure that the vaccine is available. The federal government will provide 13.5 million free flu shots via its National Immunisation Program. The flu vaccine does not provide protection against the coronavirus.
CSL LIMITED – ASX CSL, SEQIRUS PTY LTD, SIGMA HEALTHCARE LIMITED – ASX SIG, AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED – ASX API